The genetics questions you actually wonder about,
answered by people who actually know.

This is more complicated than it sounds, so let me start with the big picture. Genomics changed medicine by reading the blueprint. Multi-omics is changing it again by reading everything that happens after the blueprint is drawn. Your DNA tells you what your body is set up to do, but genetics alone explains only a portion of why people get sick or stay well. The rest involves something far more dynamic, and until recently, far harder to measure.

So what does 'omics' actually mean? The suffix refers to the comprehensive study of an entire class of biological molecules. Genomics studies your entire genome, all your DNA. Transcriptomics studies the RNA your cells are actively producing right now. Proteomics studies the proteins that cells are making. Metabolomics studies the small molecules and metabolic byproducts circulating in your blood. Epigenomics studies the chemical modifications sitting on top of your DNA that switch genes on or off without changing the underlying sequence.

Multi-omics is the integration of two or more of these layers at once, to build a far more complete picture of what is actually happening inside a person's body, not just what their DNA makes possible.

Arjun has laid out the layers, let me get at what people actually want to know: what does multi-omics reveal that genomics alone cannot?

Take Type 2 diabetes. Genomics can flag that someone carries variants linked to insulin resistance. But two people with identical genetic risk can end up on completely different metabolic trajectories, depending on diet, activity, stress, and gut microbiome. This is exactly the gap multi-omics closes. A metabolomic profile can show insulin resistance actively developing, years before blood glucose would cross a diagnostic threshold, by detecting the specific cluster of metabolites that precede clinical disease. Combine that with genomic risk and lifestyle data, and a clinician is not just identifying who is at risk in theory. They are identifying who is actively on the disease trajectory right now, with years of runway to intervene.

Cancer research shows the most dramatic version of this. Multi-omics can map a tumour's complete molecular landscape (which proteins it is producing, what metabolic pathways it depends on, how the surrounding immune environment is organised) enabling treatment decisions that genomic data alone simply cannot support. In neurological disease, similar approaches are revealing protein aggregation patterns and inflammatory signatures years before symptoms of conditions like Alzheimer's appear.

There is a specific Indian angle worth naming directly: India carries a heavy burden of complex diseases (diabetes, cardiovascular disease, certain cancers) with patterns that genuinely differ from Western populations, who make up most existing reference data. Indian populations remain significantly underrepresented in global multi-omics databases. As that gap closes through India-specific research, the precision of multi-omics insights for Indian patients should improve substantially, and whichever effort builds the most comprehensive dataset for this population will shape preventive medicine for well over a billion people.

Quick reality check on why this took so long to become usable: the hard part of multi-omics was never collecting the data. It is integrating it.

Each omics layer produces enormous volumes of information, and the scale and complexity of combining them exceeds what conventional statistics can handle cleanly. This is genuinely where AI earns its place in the conversation: deep learning and cross-omic integration methods can find patterns across billions of data points that no human analyst would catch manually, and translate those molecular signatures into something a clinician can actually act on. Without AI-driven integration, you are left with a mountain of measurements and no practical way to read them. That is the real reason multi-omics is only now becoming commercially and clinically viable, despite the individual technologies existing for years.

Frequently asked:

What is the difference between genomics and multi-omics? Genomics studies your fixed, inherited DNA sequence. Multi-omics integrates multiple biological layers, including active gene expression, proteins, metabolites, and epigenetic modifications, to build a dynamic picture of what your body is doing right now, not just what it is capable of.

Is multi-omics testing available to consumers today? Individual components, particularly genomic and metabolomic testing, are increasingly accessible. Fully integrated multi-omics panels remain more common in research and specialised clinical settings, though consumer access is expanding as costs decline.

Why is multi-omics considered the future of precision medicine? Because no single biological layer explains enough on its own. Disease emerges from the interaction between genes, proteins, metabolites, and environment, and multi-omics is currently the only framework built to capture all of that simultaneously.

How does AI fit into multi-omics? AI identifies patterns across multi-omics datasets that are too large and high-dimensional for traditional statistical methods, making it possible to detect disease signatures early and generate genuinely personalised insights from the combined data.

Does multi-omics have specific relevance for Indian health? Yes. Indian populations carry distinct genetic and metabolic profiles not well represented in Western-derived reference databases. Multi-omics research built specifically on Indian cohorts can reveal disease mechanisms and risk thresholds calibrated to Indian biology, rather than borrowed from someone else's.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

This is more complicated than it sounds, so let me explain why, starting with the big picture. Genomics changed medicine by reading the blueprint. Multi-omics is changing it again by reading everything that happens after the blueprint is drawn. Your DNA tells you what your body is set up to do. But genetics alone answers roughly 20 to 25 per cent of why people get sick or stay well. The remaining 75 to 80 per cent involves something more dynamic, more complex, and until recently, far harder to measure. Multi-omics is the field that closes this gap, and it is beginning to move from elite research settings into clinical and consumer health applications.

First, what is 'omics' at all? The suffix 'omics' refers to the comprehensive study of a particular class of biological molecules. Genomics studies the entire genome, all your DNA. Transcriptomics studies all the RNA molecules actively being produced by your cells. Proteomics studies all the proteins your cells are making. Metabolomics studies all the small molecules and metabolites circulating in your body. Epigenomics studies the chemical modifications on your DNA that switch genes on and off without changing the sequence. Each of these layers tells a different part of the same story about how your body works.

So what is multi-omics specifically? It is the integration of data from two or more of these omics layers simultaneously to build a more complete picture of biological function, disease, and health. Genomics tells you what genes you carry. Multi-omics tells you what those genes are actually doing right now, how they are being modified by your environment, what proteins they are producing, and what metabolic state those proteins are creating in your body at this specific moment.

It helps to break down each layer, because they are not interchangeable. Genomics is the foundation: your DNA sequence is static and reveals inherited risk and structural blueprint. Transcriptomics reveals which of your genes are currently switched on and off, giving a live view of which parts of your blueprint your cells are reading. Proteomics measures proteins, the molecules that actually carry out biological work, reflecting the true functional state of your tissues. Metabolomics captures the small molecules circulating in your blood, urine, and tissues as the end products of all biological processes, and is exquisitely sensitive to diet, medication, stress, and environment. Epigenomics studies the chemical tags on DNA that regulate gene expression without changing the sequence, influenced by lifestyle, environment, and ageing.

Arjun has laid out the layers. Let me take the part everyone actually wants to know: what does multi-omics reveal that genomics alone cannot, and why is the field calling it the future of precision medicine?

Consider Type 2 diabetes. Genomics can identify variants that increase susceptibility to insulin resistance, but two people with identical genetic risk can have very different metabolic trajectories based on diet, exercise, stress, and gut microbiome. Multi-omics closes this gap: a metabolomic profile can show that insulin resistance is actively developing, even before blood glucose rises to diagnostic levels, by identifying the cluster of metabolites that precede clinical disease by years. Combined with the genomic risk flag and lifestyle data, a clinician can identify not just who is at risk, but who is actively on the disease trajectory right now, and intervene years before a diagnosis would otherwise be possible.

Cancer research has provided the most dramatic demonstrations. Multi-omics maps the complete molecular landscape of a specific tumour, including which proteins it is producing, what metabolic pathways it relies on, and how the immune environment around it is organised, enabling treatments impossible to design with genomic data alone. In neurological disease, proteomics-based multi-omics is revealing the protein aggregation patterns, inflammatory metabolite signatures, and epigenetic modifications that precede Alzheimer's symptoms by years, making genuine early detection possible for conditions previously untreatable before symptoms appeared.

There is a specifically Indian dimension to all this. India carries a substantial burden of complex, multifactorial diseases, including diabetes, cardiovascular disease, neurological conditions, and specific cancer patterns that differ from Western populations. Multi-omics offers India the ability to build disease models calibrated to Indian biology, Indian dietary patterns, Indian environmental exposures, and Indian genetic diversity. Indian populations are significantly underrepresented in global genomic and multi-omics databases. As Indian genomics companies like MapMyGenomics invest in building India-specific reference data, the precision of multi-omics insights for Indian patients improves dramatically. The country that builds the most comprehensive multi-omics dataset for its population will define the future of preventive medicine for a billion people.

Quick reality check on why this has taken so long to become usable: the challenge of multi-omics is not data collection. It is data integration.

Each omics layer generates enormous volumes of information whose scale, dimensionality, and heterogeneity exceed conventional statistical methods. AI, particularly deep learning and cross-omic integration algorithms, identifies patterns across billions of data points no human analyst could detect, translates complex molecular signatures into actionable clinical insights, and builds predictive models that continuously improve as more data is added. AI is what makes multi-omics clinically and commercially viable. Without it, you have a mountain of measurements and no way to read them.

Frequently asked:

What is the difference between genomics and multi-omics? Genomics studies your DNA sequence, which is fixed and inherited. Multi-omics integrates data from multiple biological layers, including transcriptomics (active genes), proteomics (proteins), metabolomics (metabolites), and epigenomics (gene expression modifications), to build a comprehensive, dynamic picture of how your body is actually functioning. Genomics tells you what is possible; multi-omics tells you what is currently happening.

Is multi-omics testing available to consumers today? Individual components, particularly genomics and metabolomics, are increasingly available through platforms like MapMyGenomics. Full integrated multi-omics panels are currently more accessible in clinical research settings, but consumer availability is expanding rapidly as costs decline and AI interpretation tools improve.

Why is multi-omics considered the future of precision medicine? Because no single data layer explains enough. Disease is a product of the interaction between your genes, proteins, metabolites, and environment. Multi-omics is the only framework capable of capturing all these interactions simultaneously, making it possible to detect disease earlier, predict outcomes more accurately, and match individuals to interventions with greater precision.

How does AI connect multi-omics data into actionable insights? AI uses deep learning to find patterns in multi-omics datasets too complex and high-dimensional for conventional statistical analysis. It can identify molecular signatures of disease before symptoms appear, classify variants by clinical significance, and generate personalised recommendations based on the integrated picture of an individual's biology.

Does multi-omics have specific applications for Indian health? Yes, significantly. Indian populations carry distinct genetic architectures and metabolic profiles not well captured by Western-derived reference databases. Multi-omics research built on Indian cohorts can reveal disease mechanisms, risk thresholds, and intervention responses specific to Indian biology.

How is multi-omics different from a standard wellness DNA test? A standard wellness DNA test analyses your fixed genetic variants to reveal predispositions. Multi-omics goes further by also measuring dynamic biological activity, including protein levels, metabolite signatures, and gene expression patterns, to show not just what you are predisposed to, but what your body is actively doing right now.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

Great question, this comes up a lot in clinic. Walk into any clinic in India, and you will likely be handed a list of routine blood tests. Cholesterol, sugar, vitamin D, thyroid, the usual suspects. For decades, blood tests have been the gold standard of preventive health checks. But in the last few years, a new player has entered the conversation: DNA testing. So what is the actual difference between a blood test and a DNA test? Which one should you take? And why does it matter for Indians more than ever before?

First, what a blood test actually tells you. A blood test gives you a snapshot of your current health. It measures things like glucose levels, cholesterol, vitamin levels, liver function, kidney function, hormone balance, and inflammation markers. The values you see reflect what is happening in your body at that specific moment in time. Blood tests are essential. They help diagnose existing conditions, monitor ongoing diseases, and detect deficiencies. They are reactive in nature, meaning they show you what is already happening. But here is the catch. Blood tests cannot tell you what is going to happen. They cannot predict whether you are at higher risk of developing diabetes 10 years from now. They cannot tell you why certain medicines affect you differently than your friend. They are a great present-tense tool, but limited when it comes to the future.

Now, what a DNA test tells you. DNA testing is a future-oriented tool. It analyses your unique genetic code to reveal predispositions, risks, sensitivities, and personalised insights that stay with you for life. Unlike blood tests, which change every time you give a sample, your DNA stays the same. A DNA test can tell you whether you have a higher genetic risk of cardiovascular disease, Type 2 diabetes, certain cancers, or neurological conditions. It can reveal how your body processes caffeine, alcohol, fats, carbohydrates, and even specific medications. It can show your fitness profile, your skin sensitivities, your sleep patterns, and your nutritional needs at a deep biological level. This is proactive health. Instead of waiting for problems to show up in a blood test, DNA testing helps you act early, often before symptoms even appear.

The simplest way to think about the core difference is this. A blood test tells you what is happening today. A DNA test tells you what could happen tomorrow. Blood test values change with diet, lifestyle, season, and stress. DNA results do not change. Blood tests are excellent for detecting current diseases, deficiencies, and infections. DNA tests are excellent for predicting risks, personalising lifestyle decisions, and guiding long-term wellness planning. Used together, they create the most powerful health prevention system available today.

Why do Indians need both? India is a country with some of the highest rates of lifestyle diseases in the world. Indians develop diabetes nearly a decade earlier than their Western counterparts. Heart disease rates are alarmingly high, often striking people in their 30s and 40s. For most Indians, an annual blood test is not enough. It tells you what is happening this year. But it cannot tell you why you keep gaining weight despite eating healthy, why your cholesterol keeps creeping up despite exercising, or why your family has a history of heart disease that you are quietly walking into. A DNA test fills this gap. It gives you context and direction, and when paired with regular blood testing, you get a complete health picture that is both reactive and predictive.

A real-life comparison helps here. Imagine two friends, both 35, both Indian, both leading similar lifestyles. Both go for an annual blood test and both reports look identical. Normal sugar, normal cholesterol, normal everything. Now imagine they both also do a DNA test. One discovers they carry a high genetic risk for Type 2 diabetes. The other does not. The first friend can now take preventive action years before symptoms appear by adjusting their diet, monitoring sugar levels more often, and exercising strategically. Same blood test. Same numbers. Completely different futures.

Adding a few practical, clinical notes my colleagues sometimes skip over.

How often should you test? Blood tests should be done at least once a year, more often if you have specific conditions. They are dynamic and need monitoring. DNA tests are typically done only once in a lifetime. Once you have your genetic blueprint, you have it forever, and you can revisit your DNA report whenever new information is needed, whether for planning a pregnancy, optimising fitness, choosing the right diet, or making medical decisions.

On cost, accessibility, and the Indian context. A few years ago, DNA testing was prohibitively expensive and largely inaccessible to the average Indian. Today, that has changed. With the rise of advanced labs and consumer-friendly platforms like MapMyGenomics, DNA testing is becoming more affordable and accessible across Tier 1 and Tier 2 cities. Sample collection is non-invasive, often just a cheek swab. For families planning long-term wellness, DNA testing is fast becoming a smart, one-time investment.

So what does the future of Indian healthcare look like? The most powerful health strategy for Indians today is combining both. Use blood tests to monitor your current state. Use DNA testing to understand your long-term blueprint. Together, they create a personalised, preventive, and proactive approach to health that the country has never had before.

Frequently asked:

Is DNA testing better than blood testing? Neither is better. They serve different purposes. Blood testing reveals current health. DNA testing reveals long-term risks and personalised insights. Both are needed for a complete health picture.

Do I need to repeat my DNA test every year? No. Your DNA does not change. Once tested, your genetic information stays the same and can be referenced throughout your life.

Can a DNA test diagnose a disease? DNA tests do not diagnose existing diseases. They reveal genetic risks, sensitivities, and predispositions. Blood tests and clinical evaluation are still required for diagnosis.

Is DNA testing safe and accurate? Yes. Modern DNA tests from accredited labs are highly accurate. Sample collection is non-invasive, usually through a simple cheek swab. Privacy and data security are also closely safeguarded.

Should I take a DNA test even if my blood reports are normal? Yes. Normal blood reports show that nothing is wrong today. A DNA test helps you understand what could go wrong tomorrow and how to prevent it.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

Partly genetic, genuinely complicated, and surrounded by more misunderstanding and more historical misuse than almost any other question in genetics. I will give you the honest scientific picture, but I want to flag up front that this is a topic where overconfident answers in either direction, "it is all genes" or "it is all environment," are both wrong and both have done real harm. The careful answer is less satisfying and far more accurate.

Let us define terms first, because most arguments about this are really arguments about definitions. "Intelligence" as measured by tests is a narrow, specific thing, and it is not the same as wisdom, creativity, practical skill, emotional intelligence, or worth as a human being. When scientists study the heritability of intelligence, they are studying performance on particular kinds of cognitive tests, not the full richness of a human mind. Keep that distinction in hand, because the science says nothing about most of what we actually value in people.

With that framing, here is what twin and family studies suggest. Performance on cognitive tests does have a substantial heritable component, meaning a meaningful share of the variation between people in these scores is associated with genetic differences. But this heritability is not a single fixed number. Strikingly, it appears to change with circumstances, tending to be lower in conditions of deprivation and higher in conditions of plenty. That pattern alone tells you environment is not a minor footnote. When basic needs are unmet, environment dominates. When they are met, genetic differences have more room to show.

I want to jump in here because the way this question lands in real families matters enormously, and it is often where the harm happens.

Parents sometimes ask me a version of this question hoping to find out whether their child is "destined" to be brilliant or doomed to struggle, and I always slow that conversation down, because the premise is flawed. Even where genetics influences cognitive ability, it does so through hundreds or thousands of variants each contributing a tiny amount, with no single "intelligence gene" to find. Anyone claiming to test your child's DNA and tell you how clever they will be is selling you something the science cannot support. The interaction between those many variants and a child's environment, nutrition, schooling, stimulation, love, and opportunity is so dense that no genetic test can hand you a destiny.

And here is the part I most want parents to hear. The environmental factors are not just real, they are the ones you can actually influence. A child's nutrition in early life, which in the Indian context connects directly to issues like early childhood undernutrition that remain serious here, their access to education, the stimulation and security of their home, all measurably shape cognitive development. Focusing on a genetic score you cannot change, while those powerful and changeable factors sit right in front of you, gets the priorities exactly backwards.

Let me address the uncomfortable history directly, because pretending it does not exist is how it repeats.

The science of intelligence and genetics has been repeatedly misused to justify racism, casteism, eugenics, and discrimination, by people who took a genuinely complex and uncertain science and flattened it into confident, false claims about the superiority of some groups over others. This history is not a side note. It is central to why responsible scientists are so careful here. The genetics of cognitive test performance tells you about variation between individuals within a population, and it absolutely does not license claims about differences between groups, which are confounded by environment, history, opportunity, and the well-documented bias built into many tests themselves.

So when someone confidently tells you a particular group is innately smarter or less smart, they are not reporting science. They are misusing it, usually to justify something they already believed. The actual science is humble, hedged, and full of uncertainty, which is precisely what makes it trustworthy and precisely why it resists the simple stories people want from it.

For everyday purposes, the takeaway is freeing rather than limiting. Your genes are not a cognitive sentence handed down at birth. They are one influence among many, interacting constantly with an environment that does real work and that, unlike your DNA, can be improved.

Frequently asked:

Is intelligence inherited? Performance on cognitive tests has a substantial heritable component, but it is shaped by many genes and heavily by environment, and it is not fixed or determined by DNA alone.

Can a DNA test tell me how intelligent my child will be? No. Cognitive ability involves thousands of variants interacting with environment. Any test claiming to predict a child's intelligence from DNA is overselling far beyond the science.

Does genetics explain differences between groups? No. Within-population variation says nothing reliable about between-group differences, which are confounded by environment, opportunity, history, and test bias. Claims otherwise misuse the science.

If intelligence is partly genetic, does environment still matter? Enormously. Nutrition, education, stimulation, and security strongly shape cognitive development, and these are the factors you can actually influence, unlike inherited DNA.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

Substantially genetic, more than most people want to hear, and that resistance is exactly why the "just wake up earlier and you'll become a morning person" advice fails so many people.

Your tendency toward morningness or eveningness is called your chronotype, and large genetic studies have now identified hundreds of locations across the genome that influence it. Genes that run your internal body clock, with names like PER and CRY and a well-studied one called CLOCK, set the timing of your natural sleep-wake rhythm. These genes drive a roughly 24-hour internal cycle that governs when you naturally feel alert and when you naturally feel sleepy. For a strong morning person, that internal clock runs slightly early. For a strong night owl, it runs late. This is not preference. It is the timing of a biological oscillator you were largely born with.

The honest figure from twin and population studies is that something like 40 to 50% of the variation in chronotype is heritable. That is a large slice for a behavioural trait. It means a meaningful part of whether you bounce up at 5am or feel human only after 10am was decided before you had any say in the matter.

I want to add the part that actually helps people, because "it is genetic" can sound like a dead end, and it is not.

Your chronotype is not one fixed point for life. It shifts predictably with age, and this trips up entire families. Young children are often natural early risers. Teenagers shift dramatically later, which is biological and not laziness, and is the single biggest reason early school start times are so brutal for them. Then through adulthood the clock gradually drifts earlier again, which is why so many people in their fifties and sixties find themselves waking early whether they want to or not. So a teenager who cannot function at 6am and a grandparent who is wide awake at 5am are not in conflict. They are simply at different points of the same moving curve.

The practical message I give people is this. You cannot turn a genuine night owl into a genuine morning lark by willpower. But you can shift your clock within your genetic range using light, timing, and consistency. Bright light early in the day pulls your clock earlier. Screens and bright light late at night push it later. Most people are living somewhere inside their possible range, not at its edge, and that is the room you have to work with.

One myth worth retiring: that being a morning person is morally superior, more disciplined, or a marker of success. It is not. It is a clock setting, not a virtue. The "5am club" framing quietly shames night owls for biology they did not choose, and it ignores that plenty of high-performing people do their best work late at night.

The thing that actually matters for health is not whether you are early or late. It is whether your schedule matches your chronotype. A night owl forced permanently onto an early schedule lives in a state researchers call social jetlag, a chronic mismatch between body clock and alarm clock that is linked to worse sleep, mood, and metabolic outcomes. The goal is alignment, not conformity to someone else's idealised morning routine.

Frequently asked:

Can a night owl become a morning person? Not fundamentally, but you can shift your clock earlier within your genetic range using morning light, consistent timing, and limiting late-night light exposure.

Why are teenagers so bad at mornings? Their body clock biologically shifts later during adolescence. It is genuine biology, not laziness, which is why early school starts are so hard on them.

Does chronotype change as you age? Yes. It tends to run early in childhood, shift late in the teens, then gradually drift earlier again through later adulthood.

Is being a morning person healthier? Not inherently. What matters for health is whether your schedule matches your natural clock, not whether that clock runs early or late.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

This is more interesting than it sounds - let me explain why.

Yes, you got 50% of your DNA from each parent. But "look like" is determined by a small subset of your DNA - maybe a few hundred variants that influence visible facial features, skin tone, hair, eye shape. Which half of each parent's DNA you got is random, and the random draw might have given you most of the appearance-relevant variants from one side.

So you can be 50/50 by total DNA and 80/20 by visible-trait DNA. That's not a contradiction. It's exactly what the maths predicts will happen sometimes.

There's also a less obvious factor: dominant versus recessive alleles. If your mother contributed a dominant variant for, say, a strong jawline, and your father contributed a recessive one, you'll show your mother's jawline even though you carry both versions in your DNA. Your kids could still inherit the recessive one and look more like their grandfather.

So: 50/50 in DNA. Highly variable in appearance. Both true.

Great question, this comes up a lot when families bring babies in.

To add to Arjun's answer: people sometimes notice that a child looks like one parent for a few years and then "switches" to looking like the other parent. This is also real. The genes for facial structure express themselves at different rates as the face grows - toddler features are dominated by certain variants, adolescent features by others, and adult features by yet others.

The same child, photographed at 3, 13, and 30, can convincingly look like a different parent in each photo.

Partly genetic, but far less than almost everyone assumes, and that surprises people every single time.

Roughly 10% of people are left-handed, and that figure has been remarkably stable across cultures and across centuries. You would expect something that consistent to be tightly controlled by genes. It is not. Twin studies tell the story cleanly. Identical twins, who share essentially all of their DNA, are not always the same handedness. In fact, a meaningful share of identical twin pairs include one left-hander and one right-hander. If handedness were strongly genetic, that should be rare. It clearly is not, and that single fact rules out any simple "left-hand gene" explanation.

The current estimate is that genetics explains roughly a quarter of the variation in handedness. Dozens of gene variants each nudge the odds slightly, and many of them are involved in how the developing brain and body establish their left-right asymmetry in the first place. There is no master switch. Anyone who claims to have found "the gene for left-handedness" is overselling a small piece of a large and messy puzzle.

So what fills the other three-quarters? A combination of development before birth and a large dose of plain biological randomness in how an individual brain wires itself. Handedness appears to be partly set very early, well before a baby ever picks up a crayon, which is why it feels so fixed and so hard to override later.

Adding the family-pattern piece, because that is usually what people are really asking when they ask if it is "genetic."

Two right-handed parents have about a 10% chance of having a left-handed child, the same as the population average. If one parent is left-handed, that chance rises modestly. If both parents are left-handed, it rises further, but even then it stays well under a coin flip. So handedness does cluster a little in families, just far more weakly than strongly inherited traits like eye colour or height. A left-handed child in a fully right-handed family is completely ordinary and needs no explanation.

I also want to retire an old worry that still lingers, especially among grandparents. Forcing a naturally left-handed child to write with their right hand, which was common a generation ago across much of India, has no benefit and can cause real frustration, slower writing, and unnecessary distress. Handedness is a feature of how the brain is organised, not a bad habit to be corrected. If a child reaches naturally for the left hand, let them.

One myth worth killing while we are all here: left-handedness is not linked to higher intelligence, and it is not a deficit either. Both the "left-handed genius" trope and the older "left-handed disadvantage" idea are folklore. Left-handers are slightly overrepresented in a few specific domains, and you can find impressive names on any such list, but the effects are small and easily inflated by selective storytelling, where we remember the famous left-handers and quietly ignore the famous right-handers.

For everyday purposes, your handedness predicts which hand reaches for the pen and not much else of consequence about who you are. It is one of those traits that feels like it should mean something deep, and mostly just does not.

Frequently asked:

Can you tell a baby's handedness before birth? Not reliably. Early hand preference can sometimes appear in the womb, but it is not a clean genetic prediction you can order from a test.

Why are there more right-handed people? The strong human skew toward right-handedness is ancient and not fully explained, but it likely reflects how our brains organise language and motor control.

Is mixed-handedness genetic too? Handedness sits on a spectrum, and where you land is shaped by the same mix of weak genetic influence and early brain development.

Should a left-handed child be encouraged to switch? No. There is no benefit, and switching can cause real frustration. Handedness reflects brain organisation, not a habit needing correction.

22+ questions answered · Reviewed by certified counsellors · We don't sell anything · Free, always

Partially, yes. But "genetic" is doing a lot of work in that question - let me unpack it.

Heritability estimates for major depressive disorder cluster around 35 to 40% based on twin studies. That means roughly 35–40% of the variation in who develops depression versus who doesn't is explained by genetic variation in the population. The remaining 60–65% is environmental - trauma, stress, sleep, social context, medical conditions, life events.

What "genetic" doesn't mean here: there is no "depression gene." Hundreds, possibly thousands, of variants each contribute a small amount to risk. A polygenic risk score for depression is real but still has limited predictive value at the individual level - it tells you whether your risk is somewhat above or below average, not whether you'll develop depression.

What it does mean: if a parent or sibling has depression, your own risk is approximately 2 to 3 times higher than the general population. That's meaningful. But it is still a much smaller effect than what your life circumstances and access to support will do.

Genetics loads the dice. Environment rolls them.

One more useful piece of context.

The hunt for "depression genes" had a famously rough decade. Several candidate genes that early studies identified - particularly 5-HTTLPR, the serotonin transporter variant - failed to replicate in larger studies. The field has shifted from looking for individual genes to looking at the cumulative effect of thousands of small-effect variants, which is what polygenic risk scores try to capture.

The current honest summary: depression has a genetic component that is real, complex, distributed across the genome, and not yet useful for personal prediction. The most useful thing to know about your depression risk is still your own history and your family history - not your DNA test.

Yes, easily. The school version of eye colour genetics is one of the most oversimplified things still taught.

The textbook story - brown is dominant, blue is recessive, two brown-eyed parents can have a blue-eyed child only if both are heterozygous carriers - is roughly right but misses most of the action.

Eye colour is actually polygenic. At least 16 genes are known to contribute, with OCA2 and HERC2 doing most of the work, but TYR, IRF4, SLC24A4, and several others all kick in. A person's eye colour is the result of many variants combining, and the outcome isn't a clean dominant/recessive split.

In practice: two brown-eyed parents can absolutely have a blue-eyed child if both carry the right combination of variants - and this happens fairly often. It can also happen if one parent's brown eyes are due to one set of variants and the other parent's brown eyes are due to a different set, and the child happens to inherit a combination that produces low melanin in the iris.

The reverse - two blue-eyed parents having a brown-eyed child - is rarer but also possible, for similar reasons.

If your Class 10 biology textbook claimed otherwise, your textbook was using a 60-year-old model.

Statistically tall, yes. Predictably tall, no.

The Galton phenomenon - named after Francis Galton, who first measured it in the 1880s - is called "regression to the mean." Galton found that very tall parents had tall children, but their children tended to be slightly shorter than them on average. Very short parents had short children, but their children tended to be slightly taller than them on average. The next generation drifts back toward the population average.

The reason is statistical. Adult height is influenced by thousands of genetic variants. Tall parents tend to have many of the "tall" variants but not all of them. Their children inherit a random subset and on average regress toward the population mean.

The rule of thumb that paediatricians use: a child's adult height tends to fall within a range called the mid-parental height - average the two parents' heights (adjusted for sex), with a confidence interval of about 8–10 cm on either side. So two parents who are both 180 cm tall will most likely have children in the range of 170 to 190 cm, with the centre of the distribution slightly below 180.

Nutrition and childhood health also play significant roles. A genetically tall child who was malnourished in early childhood may not reach their genetic potential. A genetically average child with excellent nutrition may exceed expectations.

Tall parents tilt the odds. They do not guarantee outcomes.